Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    -0.11 (-8.40%)
Bid:
1.10
Ask:
1.30
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

FundamentalVR contract win

1 Dec 2020 07:00

RNS Number : 0088H
Tern PLC
01 December 2020
 

REACH

 

1 December 2020

 

Tern Plc

("Tern" or the "Company")

 

FundamentalVR contract win

 

Tern Plc (AIM:TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to announce that its portfolio company, FVRVS Limited ("FundamentalVR"), has secured a three year contract worth a minimum of £0.9 million from a new client, which is a global medical device company (the "Client"), to accelerate the adoption, and subsequent safe and compliant use, of the Client's product.

 

The contract is for the creation of a virtual reality ("VR") platform, that will be embedded on a VR headset to accompany every installation of the Client's product, to teach and provide assistance to the end user. As well as covering the configuration of FundamentalVR's platform, the contract will also deliver recurring annual revenues over its three-year term from licences and support. The rollout of the VR simulation is intended to deliver the Client's ambitions to accelerate the safe and compliant use of their products by using FundamentalVR's unique HapticVRTM and multiuser @HomeVRTM technologies to provide users with the opportunity to rehearse, practice, and test themselves within a safe, controllable space that is as close to real-life as possible.

 

Commenting Al Sisto, CEO of Tern, said: "We are very pleased that FundamentalVR has secured this further significant contract win. This contract and the recently announced follow-on order from a global pharmaceutical client are, we believe, strong validations of FundamentalVR's technology. We look forward to the continuing progress of FundamentalVR and the securing of further contracts from their significant pipeline of opportunities."

 

Enquiries

 

Tern Plc

Al Sisto (CEO)

Sarah Payne (CFO)

via IFC Advisory

 

Allenby Capital Limited

(Nominated Adviser and Broker)

David Worlidge / Alex Brearley (Corporate Finance)

Guy McDougall (Equity Sales)

 

Tel: 0203 328 5656

 

IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Chandler

 

Tel: 0203 934 6630

tern@investor-focus.co.uk

 

About FundamentalVR

 

FundamentalVR delivers VR haptic 'flight simulators' for surgery creating a safe, measurable and repeatable space to refine skills. FundamentalVR's goal is to transform the way surgeons prepare, practice, and refine their skills. It has built an immersive, surgical simulation application platform, Fundamental Surgery, to provide medical professionals with the opportunity to rehearse, practice, and test themselves within a safe, controllable space that is as close to real-life as possible.

 

Tern's shareholding in FundamentalVR is 26.9% and as at 30 June 2020 this holding had a book valuation of £3.0 million.

 

About Reach announcements

 

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFITLILIVII
Date   Source Headline
12th Nov 20197:05 amEQSTern PLC: Portfolio and Investments Update
6th Nov 20197:01 amEQSTern PLC: Holdings in Company
31st Oct 20197:35 amEQSTern PLC: DA and Venafi Announce Code Signing Service Integration for KeyScaler
30th Oct 20197:03 amEQSTern PLC: Equity Fundraise of c. £1.75m
30th Oct 20197:00 amEQSTern PLC: FundamentalVR Series A Funding Round
25th Oct 20194:41 pmRNSSecond Price Monitoring Extn
25th Oct 20194:35 pmRNSPrice Monitoring Extension
17th Oct 20194:41 pmRNSSecond Price Monitoring Extn
17th Oct 20194:35 pmRNSPrice Monitoring Extension
2nd Oct 20197:00 amEQSTern PLC: Shareholder Conference Call
26th Sep 20197:01 amEQSTern PLC: Issue of further convertible loan to Device Authority
25th Sep 20197:01 amEQSTern PLC: Unaudited Interim Results for the six months to 30 June 2019
25th Jul 20193:25 pmEQSTern PLC: New commercial order for FundamentalVR
24th Jun 20199:01 amEQSTern PLC: New Partnership for Device Authority
24th Jun 20197:02 amEQSTern PLC: Wyld Networks is awarded Innovate UK grant and appoints new CEO
24th Jun 20197:01 amEQSTern PLC: Capital Markets Day
9th May 20197:01 amEQSTern PLC: Tern to present at Mello 2019
30th Apr 20195:00 pmEQSTern PLC: Total Voting Rights
25th Apr 20192:20 pmEQSTern PLC: Result of Annual General Meeting
23rd Apr 20199:00 amEQSTern PLC: Device Authority announces new strategic partnership and joint customer collaboration for the Internet of Medical Things ('IoMT')
15th Apr 20191:00 pmEQSTern PLC: Device Authority announces new strategic alliance
11th Apr 20197:00 amEQSTern PLC: Device Authority Update - issue of further convertible loan
4th Apr 20197:01 amEQSTern PLC: Shareholder Conference Call
3rd Apr 20199:05 amRNSSecond Price Monitoring Extn
3rd Apr 20199:00 amRNSPrice Monitoring Extension
3rd Apr 20197:01 amEQSTern PLC: Equity Fundraise of c. £1.5m
1st Apr 20197:00 amEQSTern PLC: New commercial order for InVMA
26th Mar 201910:10 amEQSTern PLC: New commercial order for FundamentalVR
19th Mar 20199:10 amEQSTern PLC: Device Authority Board Appointments
19th Mar 20197:01 amEQSTern PLC: Final results for the year ended 31 December 2018
4th Mar 20197:00 amEQSTern PLC: flexiOPS Business Update
20th Feb 20197:00 amEQSTern PLC: Update re. Convertible Loan to Device Authority Limited
31st Jan 20199:30 amEQSTern PLC: Further re. Long Term Contract Win for Device Authority
14th Jan 20197:00 amEQSTern PLC: Issue of further convertible loan to Device Authority Limited
3rd Jan 20195:16 pmEQSTern PLC: Holdings in Company
31st Dec 20187:01 amEQSTern PLC: Extension of Device Authority Convertible Note Maturity Date
27th Dec 20187:01 amEQSTern PLC: Long term contract win for Device Authority and Further re Portfolio Update
11th Dec 201812:30 pmEQSTern PLC: Device Authority Contract Win
27th Nov 201811:05 amRNSSecond Price Monitoring Extn
27th Nov 201811:00 amRNSPrice Monitoring Extension
23rd Nov 20182:34 pmEQSTern PLC: Holdings in Company
22nd Nov 20187:00 amEQSTern PLC: Portfolio Update
13th Nov 20184:29 pmEQSTern PLC: AIM Director Disclosure Update
30th Oct 20187:01 amEQSTern PLC: Additional Investment in FundamentalVR
17th Sep 20187:01 amEQSTern PLC: Unaudited Interim Results for the six months to 30 June 2018
14th Sep 20187:01 amEQSTern PLC: Issue of further loan to Device Authority Limited
31st Aug 20185:00 pmEQSTern PLC: Total Voting Rights
22nd Aug 20187:00 amEQSTern PLC: Notice of Results and Shareholder Conference Call
15th Aug 20187:00 amEQSTern PLC: Fundamental Surgery Launched in the US
13th Aug 20187:01 amEQSTern PLC: Change of adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.